# Commission Implementing Regulation (EU) 2020/1685 of 12 November 2020 amending Regulation (EU) No 37/2010 to classify the substance bupivacaine as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
Pharmacologically active Substance
Marker residue
Animal Species
MRLs
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Bupivacaine
NOT APPLICABLE
Porcine
No MRL required
NOT APPLICABLE
For use in piglets up to 7 days of age only.
For cutaneous and epilesional use only.
Local anaesthetic’
Bovine
For use in calves up to 2 months of age only.
For cutaneous and epilesional use only.

---
Source: https://www.legislation.gov.uk/eur/2020/1685/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-1685/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.